Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and ...

In terms of its transformative effect, AI is doing for healthcare what electricity did for the industry. According to Fortune ...

Virtual scientists in a virtual lab at Stanford University are coming up with unorthodox ways to address clinical challenges, ...

AI correctly identified 32.6% of the interval breast cancers. Features of AI-detected cancers included larger size at ...

Even the most powerful AI models, including ChatGPT, can make surprisingly basic errors when navigating ethical medical ...

New AI technology can spot breast cancer in MRI scans more accurately than current digital methods, while also pinpointing ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...

Physicians Assess AI Tools Against 12 Frontline KPIs; 8 Solutions Surpass Expectations in Diagnostic Alignment, Workflow ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS.

NetraMark Holdings Inc. (the 'Company” or 'NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials and Pentara Corporation ( ...